treatment resistant depressive disorder
Showing 1 - 5 of 5
Treatment Resistant Depressive Disorder Trial in Beijing (HS-10345 84mg, Placebo)
Active, not recruiting
- Treatment Resistant Depressive Disorder
- HS-10345 84mg
- Placebo
-
Beijing, Beijing, ChinaBeijing Anding Hospital, Capital Medical University
Jun 13, 2022
Treatment Resistant Depressive Disorder Trial in Houston (Ketamine, Midazolam)
Completed
- Treatment Resistant Depressive Disorder
-
Houston, TexasMichael E. DeBakey VA Medical Center, Houston, TX
Dec 15, 2021
Treatment Resistant Depressive Disorder Trial in Belgium, Japan, United States (Esketamine 14 mg, Esketamine 28 mg, Esketamine
Completed
- Treatment Resistant Depressive Disorder
- Esketamine 14 mg
- +4 more
-
Birmingham, Alabama
- +24 more
May 18, 2020
Treatment Resistant Depressive Disorder Trial in Shenzhen (Bilateral implantation of DBS system to Habeluna)
Unknown status
- Treatment Resistant Depressive Disorder
- Bilateral implantation of DBS system to Habeluna
-
Shenzhen, Shenzhen, ChinaHabenula DBS
Dec 24, 2018
Depression, Depressive Disorder, Treatment Resistant Depressive Disorder Trial (Ultrabrief Right Unilateral, Brief Pulse
Withdrawn
- Depression
- +4 more
- Ultrabrief Right Unilateral
- Brief Pulse Bitemporal
- (no location specified)
Feb 15, 2017